Terms: = Pancreatic cancer AND CCNE1, CCNE, 898, ENSG00000105173, P24864 AND Treatment
14 results:
1. Value of diffusion kurtosis MR imaging and conventional diffusion weighed imaging for evaluating response to first-line chemotherapy in unresectable pancreatic cancer.
Zhang Z; Zhang Y; Hu F; Xie T; Liu W; Xiang H; Li X; Chen L; Zhou Z
Cancer Imaging; 2024 Feb; 24(1):29. PubMed ID: 38409049
[TBL] [Abstract] [Full Text] [Related]
2. The genomic and immune landscapes of gastric cancer and their correlations with HER2 amplification and PD-L1 expression.
Jing X; Luo Z; Wu J; Ye F; Li J; Song Z; Zhang Y; Shi M; Sun H; Fang Y; Jiang Y; Ji X
Cancer Med; 2023 Dec; 12(24):21905-21919. PubMed ID: 38050871
[TBL] [Abstract] [Full Text] [Related]
3. Subclonal Somatic Copy-Number Alterations Emerge and Dominate in Recurrent Osteosarcoma.
Kinnaman MD; Zaccaria S; Makohon-Moore A; Arnold B; Levine MF; Gundem G; Arango Ossa JE; Glodzik D; Rodríguez-Sánchez MI; Bouvier N; Li S; Stockfisch E; Dunigan M; Cobbs C; Bhanot UK; You D; Mullen K; Melchor JP; Ortiz MV; O'Donohue TJ; Slotkin EK; Wexler LH; Dela Cruz FS; Hameed MR; Glade Bender JL; Tap WD; Meyers PA; Papaemmanuil E; Kung AL; Iacobuzio-Donahue CA
Cancer Res; 2023 Nov; 83(22):3796-3812. PubMed ID: 37812025
[TBL] [Abstract] [Full Text] [Related]
4. Reducing relapse through maintenance steroid treatment can decrease the cancer risk in patients with IgG4-sclerosing cholangitis: Based on a Japanese nationwide study.
Kubota K; Kamisawa T; Nakazawa T; Tanaka A; Naitoh I; Kurita Y; Takikawa H; Unno M; Kawa S; Masamune A; Nakamura S; Okazaki K;
J Gastroenterol Hepatol; 2023 Apr; 38(4):556-564. PubMed ID: 36403136
[TBL] [Abstract] [Full Text] [Related]
5. Changes in natural killer cell activity after surgery and predictors of its recovery-failure.
Kim EY; Hong TH
J Surg Oncol; 2021 Dec; 124(8):1561-1568. PubMed ID: 34351633
[TBL] [Abstract] [Full Text] [Related]
6. pancreatic Frozen Section Guides Operative Management With Few Deferrals and Errors.
Chavez JA; Chen W; Freitag CE; Frankel WL
Arch Pathol Lab Med; 2022 Jan; 146(1):84-91. PubMed ID: 33769446
[TBL] [Abstract] [Full Text] [Related]
7. Olaparib Monotherapy for Previously Treated pancreatic cancer With DNA Damage Repair Genetic Alterations Other Than Germline BRCA Variants: Findings From 2 Phase 2 Nonrandomized Clinical Trials.
Javle M; Shacham-Shmueli E; Xiao L; Varadhachary G; Halpern N; Fogelman D; Boursi B; Uruba S; Margalit O; Wolff RA; Golan T
JAMA Oncol; 2021 May; 7(5):693-699. PubMed ID: 33662100
[TBL] [Abstract] [Full Text] [Related]
8. Deep Targeted Sequencing and Its Potential Implication for cancer Therapy in Chinese Patients with Gastric Adenocarcinoma.
Yu P; Wang Y; Yu Y; Wang A; Huang L; Zhang Y; Liu W; Wu H; Yao M; Du YA; Cheng X
Oncologist; 2021 May; 26(5):e756-e768. PubMed ID: 33511732
[TBL] [Abstract] [Full Text] [Related]
9. LRH-1 (liver receptor homolog-1) derived affinity peptide ligand to inhibit interactions between β-catenin and LRH-1 in pancreatic cancer cells: from computational design to experimental validation.
Pouraghajan K; Mahdiuni H; Ghobadi S; Khodarahmi R
J Biomol Struct Dyn; 2022 Apr; 40(7):3082-3097. PubMed ID: 33183172
[TBL] [Abstract] [Full Text] [Related]
10. Drug-eluting beads transarterial chemoembolization by CalliSpheres is effective and well tolerated in treating intrahepatic cholangiocarcinoma patients: A preliminary result from CTILC study.
Luo J; Zheng J; Shi C; Fang J; Peng Z; Huang J; Sun J; Zhou G; Li T; Zhu D; Xu H; Hou Q; Ying S; Sun Z; Du H; Xie X; Cao G; Ji W; Han J; Gu W; Guo X; Shao G; Yu Z; Zhou J; Yu W; Zhang X; Li L; Hu H; Hu T; Wu X; Chen Y; Ji J; Hu W
Medicine (Baltimore); 2020 Mar; 99(12):e19276. PubMed ID: 32195932
[TBL] [Abstract] [Full Text] [Related]
11. Pegylated Liposomal Irinotecan Hydrochloride Trihydrate for Treating pancreatic cancer After Gemcitabine: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Fleeman N; Abdulla A; Bagust A; Beale S; Richardson M; Stainthorpe A; Boland A; Kotas E; McEntee J; Palmer D
Pharmacoeconomics; 2018 Mar; 36(3):289-299. PubMed ID: 29178025
[TBL] [Abstract] [Full Text] [Related]
12. Marital status and survival in patients with cancer.
Aizer AA; Chen MH; McCarthy EP; Mendu ML; Koo S; Wilhite TJ; Graham PL; Choueiri TK; Hoffman KE; Martin NE; Hu JC; Nguyen PL
J Clin Oncol; 2013 Nov; 31(31):3869-76. PubMed ID: 24062405
[TBL] [Abstract] [Full Text] [Related]
13. Cell cycle control pathways act as conditioning factors for TK/GCV sensitivity in pancreatic cancer cells.
Abate-Daga D; Garcia-Rodríguez L; Sumoy L; Fillat C
Biochim Biophys Acta; 2010 Oct; 1803(10):1175-85. PubMed ID: 20599444
[TBL] [Abstract] [Full Text] [Related]
14. BRAF and FBXW7 (CDC4, FBW7, AGO, SEL10) mutations in distinct subsets of pancreatic cancer: potential therapeutic targets.
Calhoun ES; Jones JB; Ashfaq R; Adsay V; Baker SJ; Valentine V; Hempen PM; Hilgers W; Yeo CJ; Hruban RH; Kern SE
Am J Pathol; 2003 Oct; 163(4):1255-60. PubMed ID: 14507635
[TBL] [Abstract] [Full Text] [Related]
